Director, US Market Access Marketing, Antivirals (Secondment 9-12 Months)

WHY PATIENTS NEED YOU

PAXLOVID (nirmatrelvir/ritonavir) is Pfizer's oral protease inhibitor for the treatment of COVID-19. On May 25, 2023, the FDA approved PAXLOVID for mild-to-moderate COVID-19 in adults at high risk for progression to severe disease, including hospitalization or death — making it the first oral antiviral approved for adults in the U.S. and the only oral COVID-19 treatment with an AIIa recommendation in the NIH treatment guidelines. As of March 9, 2024, the transition from Emergency Use Authorization to full FDA approval is complete for adults, while the EUA remains in effect for pediatric patients 12 years and older weighing at least 40 kg.

WHAT YOU WILL ACHIEVE

The Director, US Market Access (USMA) Marketing, Antivirals secondee is a member of the USMA Marketing team who will lead US market access marketing strategy and execution for a portfolio of priority in line and launch products. Success in this role will require close interaction and communication with members of the Antiviral Franchise, USMA Channel Management, Account Management, Retail, Pricing & Contracting teams. In addition, this individual will direct and align strategies and tactics with regional and national account management, contracting strategy, Market Access Analytics, Field Medical, Global Access and Value (GAV), and other key internal stakeholders within US Market Access.

This individual will be responsible for ensuring the development, alignment, execution, and evolution of US Market Access strategies and tactics designed to deliver the compelling value story across multiple settings of care and support the development of innovative engagements within the US Market Access space. We seek a high-performing individual who has a deep understanding of the US Market Access space with experience working with US Market Access customers, brand marketing, pricing analysis, contracting, and market access analytics. The candidate should have the ability to interact with senior Antiviral Franchise and USMA leaders and should have a track record demonstrating strong leadership, marketing, communication, influence, and strategic thinking abilities.

HOW YOU WILL ACHIEVE IT

• Direct ownership and responsibility for building/enhancing USMA marketing platform and USMA access strategies across a portfolio of priority products, including commensurate accountability for and attainment of quality USMA access targets and aligned execution across functions.

• Drive and inform key decisions regarding customer USMA access assessments and negotiations in a complex and continuously evolving market.

• Leverage advanced knowledge of USMA space to lead US brand market access strategy for assigned assets, including portfolio, market archetype, and lifecycle considerations; ensure alignment of strategies and tactics across brand marketing, USMA, Global GAV, Finance, Field Medical, and other customer facing functions.

• Identify and address key product barriers to USMA access and performance by applying advanced understanding of and experience with contracting and pricing strategies, USMA analytics, and USMA market trends across Therapeutic Areas, brand lifecycle, and market channels.

• Lead evolution of broad USMA value platform leveraging deep customer insights and incorporating input from USMA Account Management, Global GAV, USMA Customer Analytics, and other internal and external stakeholders.

• Drive Customer/Brand engagement strategy for top customer accounts and lead stakeholder alignment, shape brand/account goals, and drive execution with Account Management, Customer Marketing, Contract Strategy, and Sales.

• Ensure timely endorsement with Antiviral Franchise and USMA Leadership through frequent communications and presentations; lead, inform and influence USMA-related activities and strategies with cross-functional departments including brand teams, Global GAV, and USMA.

• Represent USMA issues/opportunities within brand LTs, and consistently articulate brand strategies & priorities to USMA & Account Management Leadership Teams.

• Co-develop and communicate pricing recommendation and lead process to inform Pricing and USMA access strategy, and GTN assumptions for launch product; leverage analytics platform and inform business development decisions.

• Direct application of advanced Customer Analytics to maximize profitable USMA access opportunities.

• As applicable, Lead Asset Matrix team, a cross functional team focused on developing and aligning USMA access objectives and improving execution of advanced USMA strategies and tactics to drive business results.

• Lead ongoing discussions and opportunity assessments with account management related to key products and customers.